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Abstract
Background and objective: The decision to maintain intensive treatment in cardiac surgical patients with poor initial outcome is mostly based
on individual experience. The risk scoring systems used in cardiac surgery have no prognostic value for individuals. This study aims to assess (a)
factors possibly related to poor survival and functional outcomes in cardiac surgery patients requiring prolonged ( 5 days) intensive care unit
(ICU) treatment, (b) conditions in which treatment withdrawal might be justified, and (c) the patient’s perception of the benefits and drawbacks
of long intensive treatments. Methods: The computerized data prospectively recorded for every patient in the intensive care unit over a 3-year
period were reviewed and analyzed (n = 1859). Survival and quality of life (QOL) outcomes were determined in all patients having required 5
consecutive days of intensive treatment (n = 194/10.4%). Long-term survivors were interviewed at yearly intervals in a standardized manner and
quality of life was assessed using the dependency score of Karnofsky. No interventions or treatments were given, withhold, or withdrawn as part of
this study. Results: In-hospital, 1-, and 3-year cumulative survival rates reached 91.3%, 85.6%, and 75.1%, respectively. Quality of life assessed 1
year postoperatively by the score of Karnofsky was good in 119/165 patients, fair in 32 and poor in 14. Multivariate logistic regression analysis of
19 potential predictors of poor outcome identified dialysis as the sole factor significantly ( p = 0.027) — albeit moderately — reducing long-term
survival, and sustained neurological deficit as an inconstant predictor of poor functional outcome ( p = 0.028). One year postoperatively 0.63% of
patients still reminded of severe suffering in the intensive station and 20% of discomfort. Only 7.7% of patients would definitely refuse redo
surgery. Conclusions: This study of cardiac surgical patients requiring 5 days of intensive treatment did not identify factors unequivocally
justifying early treatment limitation in individuals. It found that 1-year mortality and disability rates can be maintained at a low level in this
subset of patients, and that severe suffering in the ICU is infrequent.
# 2006 Elsevier B.V. All rights reserved.
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Large series report less than 5% mortality and 25—45%
complications after heart surgery [1,2]. In-hospital mortality
is linked with considerable but timely limited human and
financial consequences. In contrast, the burden of severe
long-term disability persists over time. At the present time,
patients in disastrous cardiac and general condition are
increasingly referred for cardiac surgery. These patients are
at risk of prolonged intensive care unit (ICU) treatments.
Obviously, only low in-hospital andmortality rates as well as a
fair quality of life (QOL) in long-term survivors can justify the
human and socio-economical consequences of these treat-* Corresponding author. Address: Department of Cardiovascular Surgery,
Centre Hospitalier Universitaire Vaudois (CHUV), 1011 Lausanne, Switzerland.
Tel.: +41 21 314 23 18; fax: +41 21 314 22 78.
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doi:10.1016/j.ejcts.2005.12.040ments. Therefore, cessation of life-supporting measures
must be considered whenever treatment becomes futile or is
opposed to patient and family wishes. However, various lines
of evidence indicate that the approach of end-of-life
decisions differs considerably among healthcare workers
[3—5], that individual experience is selective and influenced
by recent or anecdotal cases [6], and that the physician’s
opinion tends to prevail over that of patients [7].
The risk-scoring systems commonly used in cardiac surgery
are chiefly based on preoperative risk factors and, thus, not
able to identify changing mortality and morbidity risks in
patients with unexpected perioperative complications. More-
over, these systemshavebeendeveloped to improveoperative
decisions as well as quality comparisons and cost—benefit
analysis [8]; their predictive value is much higher for groups
than for individuals [8—10]. None of these scores has been
conceived for end-stage prospective decisions or to facilitate
decisions about individuals [9]. The recent comparison of six
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evidenced the poor predictive value of each of these scores for
morbidity [10]. Hence, at present time, the decision to limit
treatment in cardiac surgical patients with apparently poor
recovery expectancy is based on experience instead of
evidence.
The objectives of this study are, first, to identify factors
possibly related to poor prognosis in cardiac surgical patients
with difficult initial outcome, second, to identify conditions
in which treatment withdrawal might be justified and, third,
to assess the patient’s perception of the benefits and
drawbacks of long ICU treatments.2. Patients and methods
2.1. Settings and routine procedures
The CHUV is an 870-bed teaching hospital with a single
surgical ICU of 17 beds and a high patient turnover. The
cardiac surgical department has six fully monitored inter-
mediate care beds; telemetry is available on the ward.
Patients operated on cardiopulmonary bypass (CPB) are
routinely admitted in the ICU and discharged to the
intermediate cardiac surgical care unit within 24—36 h unless
they further require mechanical ventilation, intra aortic
balloon pump (IABP) and/or important inotropic support
(either any dose of milrinone [Corotrop1 Sanofi-Synthe´labo,
Paris, France] or Dopamine [Dopamin1 B. Braun, Melsungen,
Germany]/Dobutamine [Dobutrex1 Lilly, Indianapolis, USA]
in excess of 8 mg/(kg min) or over 10 mg/(kg min), norepi-
nephrine [Noradrenaline1 Sintetica SA, Mendrisio, Switzer-
land]). Patients with deteriorating renal function are kept in
the ICU until blood creatinin has peaked or until renal
replacement therapy has been initiated.
In conformity with the recommendations of the SUPPORT
study [11], conscious patients and families receive frequent
information on present condition and prognosis; they are
included in discussions on major treatment decisions. No
interventions or treatments were given, withhold, or with-
drawn as part of this study.
2.2. Data collection
Cardiac surgical patients having required 5 consecutive
days in the ICU over a 3-year period were identified from the
ICU database. Heart transplant recipients and patients with
cardiac tumors were excluded. Nineteen among 44 para-
meters prospectively recorded for each patient as part of our
clinical information system (Claris File Maker Pro v2.1) were
selected as potential predictors of poor vital and functional
outcomes:- Patient-related factors: age, gender, ejection fraction
<30%, neurological impairment (defined as a disease
severely affecting day-to-day functioning or ambulation),
chronic obstructive pulmonary disease (COPD) on bronch-
odilators, insulin-requiring diabetes, obesity (BMI > 30),
dialysis-dependent renal failure, nature of surgical pro-
cedure, priority, and redo surgery.- Operative-related factors: cross-clamp and CPB times.- Life-supporting procedures: mechanical ventilator support
5 days, renal replacement therapy, IABP, surgical
revision, cardiopulmonary resuscitation, and electrical
counter shock for life-threatening arrhythmias.
The choice of these variables was founded on distinct
criteria:- Patient-related factors were selected from a review of
three major risk scoring system for cardiac surgical
patients: the Parsonnet score, the Euroscore, and the
Society of Thoracic Surgeons (STS) national database.
Significant variables in at least two systems were selected.- Life-supporting procedures required by persistent life-
threatening failure in one organ system were selected
because this condition has been shown to chiefly determine
the patient’s outcome [12—15].- Ischemic and CPB times were included in the analysis
because of their unquestionable deleterious effects on
both physiology and the clinical outcome [16].2.3. Investigations
A single independent physician collected all follow-up
data. Patients and, whenever necessary, their relatives and
home practitioners were interviewed by phone 1, 2, and 3
years after surgery. This interview was based on both the
dependency score of Karnofsky [17] and a simplified version
of the SF 12 TM Health Survey, allowing collection of standard
information on:- persistent disabilities and/or need for assistance,
- complications and diseases after hospital discharge,
- physical condition 1 year postoperatively,
- psychological condition 1 year postoperatively,
- self-assessed quality of life,
- difference between preoperative and present general
condition (improved, stable, worsened),- frequency and severity of discomfort and pain during ICU
treatment, and- attitude towards a hypothetical redo operation.
2.4. Outcomes
Main outcome measurements included: (a) early mortal-
ity, defined as any mortality occurring in the hospital or
within 30 days, (b) annual postoperative mortality rate over 3
years, (c) degree of disability 1 year postoperatively, and (d)
quality of life 1 year after surgery.
The dependency score of Karnofsky (Table 1) allowed
differentiating between patients with optimal (K 100) or
good (K 90) recovery after 1 year and those with any kind of
persistent disability (K  80), regardless of their preopera-
tive condition.
2.5. Characteristics of follow-up
Follow-up of hospital survivors ranged from12 to 48months
(average 30 months corresponding to 485 patient-years). The
response rate for the first interview reached 98.8%; missing
data (two patients) were censored at hospital discharge.
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Table 1
Main features of the Karnofsky Performance Status [14]
K value Performance
100 No complaints or evidence of disease
90 Normal activity, minor signs of disease
80 Normal activity with effort, signs of disease
70 Selfcare, unable to carry out normal activities or to work
60 Assistance needed, able to care for most of own needs
50 Requires considerable assistance and frequent medical care
40 Disabled, requires special care and assistance
30 Severely disabled
20 Supportive treatment necessary
10 Moribund2.6. Statistical analysis
Descriptive statistics were used to summarize the
demographic and clinical characteristics of the population.
Values are given as mean  SD. Two major outcomes of
interest were considered for comparative analysis: the
survival and the long-term dependency. Differences between
continuous variables were assessed by the unpaired Student’s
t-test. Categorical variables were compared using the x2-
test. All tests were two-tailed and p values 0.05 were
considered significant. Finally, suitable parameters were
considered for a multivariate logistic regression analysis to
identify independent risk factors. Analyses were performed
using the statistical software package JMP 3.1 (SAS Institute
Inc., Cary, NC, USA).3. Results
Of the 1859 consecutive adult patients operated on
cardiopulmonary bypass over a 3-year period in a single
institution, 194 (10.4%) required 5—22 consecutive days of
ICU treatment (mean 7.5  3.4 days, median 7 days). The risk
profile of these patients and the distribution of the surgical
procedures are detailed in Tables 2 and 3. Table 3 shows that
the risk of long ICU stay depends mostly on the complexity of
the surgical procedure. Oppositely, neither high surgical
priority (9.8% of patients in the prolonged group received
urgent (n = 12) or emergent (n = 7 surgery)) nor cross-clampTable 2
Preoperative risk factors of 1859 CPB patients
Variable 5 ICU days (194 patients)
Female 34%
Age (years)
Mean  SD 66.1  10.7
Median/range 68.0/20—83
18—55 years 12.8%
56—70 years 45.4%
>70 years 41.8%
LV ejection fraction <30% 12.4%
Insulin diabetes 8.2%
COPD under bronchodilators 8.7%
Obesity (BMI > 30) 17.5%
Chronic dialysis 3.1%
Previous stroke 2.6%
Redo operations 3.1%
LV: left ventricular; COPD: chronic obstructive pulmonary disease.and CPB times (80  33 min and 122  53 min, respectively,
in the prolonged group) was significantly correlated with long
ICU treatment.
3.1. Mortality
(1) Earlymortality: Of the 194 patients in the study group, 17
(8.75%) died in the hospital or within 30 days. The causes
of these deaths were as follows: cardiogenic (n = 8) or
septic shock (n = 3), pulmonary embolism (n = 3),
rhabdomyolysis (n = 1), and support withdrawal (n = 2)
at postoperative day 6 and day 9, because of poor
expected outcome after devastating stroke in the first
case and large mesenterial infarction in the second one.
In comparison, the mortality among the 1655 cardiac
surgical patients having required shorter ICU treatment
during the same period of time was 2.0% ( p < 0.001).
Table 4 details the influence of various life-supporting
measures on mortality. Prolonged assisted ventilation,
renal replacement therapy, surgical revision and, to a
less extent, intra aortic balloon pumpwere all associated
with increased 30-day mortality. However, only dialysis
( p < 0.001) and prolonged ventilation ( p < 0.01)
emerged as independent predictors of early death. ICU
length of stay for non-survivors despite ongoing full ICU
treatment averaged 10.6  5.2 days; if life support had
been withdrawn at the fifth ICU day in all patients who
ultimately died in the hospital, only 96 days of ICU
resources would have been saved.(2) Mid-term survival: Nineteen of the 177 early survivors
died during follow-up, which accounts for cumulative
survival rates of 85.6%, 80.9%, and 75.1% at 1, 2, and 3
years, respectively. The causes of late deaths are
presented in Table 5. Neither the gender nor the type
of surgical procedure, CPB and aortic cross-clamping
times were significantly related to mortality outcomes.
Age above 75 years was associated with lower ( p = 0.05)
mid-term survival (Table 6). However, seven out of eight
fatal events in these elderly patients occurred more than
1 year postoperatively, and four deaths were not clearly
related to previous cardiac and ICU treatment (two
cancers, one traffic accident, one vascular amputation).<5 ICU days (1655 patients) p
23.2% <0.01
61.0  8.4
62.5/17—88
29.6% <0.001
51.1% ns
19.3% <0.001
7.1% <0.05
4.0% ns
7.1% ns
20.8% ns
0.7% <0.01
3.7% ns
8.4% <0.01
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Table 3
Surgical procedures
Procedure Number ICU 5 days Percentage Males Females
CABG 1179 100 8.5 71 29
Valves 330 26 7.9 12 14
CABG + valve(s) 144 41 *** 28.5 27 14
Thoracic aorta 58 8 13.8 7 1
Adult congenital 69 0 0 0 0
Combined proceduresa 79 19 *** 24.1 14 5
Total 1859 194 10.4 131 63
CABG: coronary artery bypass graft.
a Cardiac and non-cardiac procedures during the same session.
*** p < 0.001.
Table 4
Influence of various life-supporting procedures on early and mid-term mortality rates
Procedure 30 days mortality
(with/without)
p Late mortality
(with/without)
p Overall mortality
(with/without)
p*/
Ventilation 5 days 14/70 versus 0/124 ***/ 4/56 versus 18/124 ns 18/70 versus 18/124 ns
Dialysis 9/24 versus 5/170 ***/ 1/15 versus 21/165 ns 10/24 versus 26/170 **/
IABP* 6/30 versus 8/164 * 0/24 versus 22/156 ns 6/30 versus 30/164 ns
Reoperation 8/34 versus 6/160 *** 2/26 versus 20/154 ns 10/34 versus 26/160 ns
Resuscitation 4/33 versus 10/161 ns 3/29 versus 19/151 ns 7/33 versus 29/161 ns
Defibrillation 3/24 versus 11/170 ns 3/21 versus 19/159 ns 6/24 versus 30/170 ns
IABP: intra aortic balloon pump.
* = x2-test.
 = Logistic regression analysis.
*/ p < 0.05.
**/ p < 0.01.
***/p < 0.001.(3) Overall mortality: Dialysis-dependent renal dysfunction
was the sole factor detrimentally affecting overall
survival in the study group ( p < 0.01). Nonetheless,
60% of the 24 patients having required any kind of renal
replacement therapy after surgery (including six patients
with preoperative chronic dialysis) were still alive and in
a fair to good condition 1 year later.3.2. Neurological complications
Twelve (6.2%) severe neurological complications occurred
in the hospital: 11 strokes (one fatal) and one paraplegia. All
occurred within 7 days of the operation.
3.3. Return in the ICU
Seven patients (4%) needed to be readmitted in the ICU
because of respiratory failure (n = 4), severe heart failure
(n = 2), and redo sternotomy for mediastinitis (n = 1). All
survived and were discharged from the ICU within 3—11 days.
Hospital readmission within 1 year occurred in 19 one-year
survivors (12%). It was unpredictable in nine patients
suffering from cardiac failure (n = 4), pneumonia (n = 2),
late stroke (n = 1), severe chest pain (n = 1), and trauma
(n = 1). Furthermore, two patients received non-emergent
surgery for non-related diseases. Oppositely, readmission had
been planned before the heart operation in eight patients
with concomitant cardiac and non-cardiac diseases (two
aortic aneurysms, three cancers, three joint disease).3.4. Quality of life
Functional and subjective results 1 year postoperatively
were obtained from 165 of the 167 survivors (Fig. 1). Seventy-
two percent had no physical symptoms or minimal physical
symptoms (K scores of 100 and 90), 19% had signs of disease (K
score of 80) but no important limitations of their activity, 6%
were disabled (K score of 70—50), and 3% were severely
handicapped (K score < 50). Disability, defined by K score less
than 80, was neither significantly related to ICU treatments
(Table 7) nor to patient profile, CPB and cross-clamp times or
type of surgery. The sole predictor ( p < 0.05) for a lasting
QOL deterioration was the occurrence of a perioperative
neurological accident. Conversely, perioperative neurologi-
cal events were implicated in 11 of the 14 cases of long-term
disability.
At 1 year, 132 patients (80%) considered themselves in
better condition as compared to their preoperative situation,
19 felt no change (11.5%) and 14 reported a degradation of
their general living conditions (8.5%). However, deterioration
was obviously related with previous in-hospital treatment in
only nine cases (four chronic cardiac failures, two severe
residual chest pain, two strokes, and one paraplegia); in the
remaining five cases deterioration was caused — or worsened
— by intercurrent diseases (two cancers, two vascular
amputations, one disabling arthrosis). Oppositely, 15
patients reported global improvement in spite of substantial
postoperative sequelae such as eight persistent neurological
deficit, two severe residual chest pain, one tracheal stenosis
after tracheotomy, one limb claudication after intra aortic
P. Gersbach et al. / European Journal of Cardio-thoracic Surgery 29 (2006) 466—472470
Table 5
Delay and cause of 19 late deaths after prolonged ICU treatment
Cause of death 1—6 months 7—12 months 13—18 months 19—24 months 25—30 months 31—36 months <36 months Total (disease)
Cancer 1 2 1 1 0 1 0 6
Heart failure 1 3 0 0 0 0 0 4
Vascular disease 0 1 1 0 0 0 0 2
Septic shock 0 1 1 0 0 0 0 2
MOF 0 0 1 0 1 0 0 2
Bleeding 0 0 1 0 0 0 0 1
Trauma 1 0 0 0 0 0 0 1
Unknown 0 0 0 0 0 0 1 1
Total/period 3 7 5 1 1 1 1 19
MOF: multiple organ failure.
Table 6
Influence of age on early and mid-term mortality
Age (years) Number of patients In-hospital deaths Percentage Mid-term deaths (1—48 months) Percentage Total Percentage
<40 6 0 0 0 0 0 0
41—45 2 1 50 0 0 1 50
46—50 8 2 25 0 0 2 25
51—55 9 1 11 0 0 1 11
56—60 21 0 0 2 9.5 2 9.5
61—65 36 4 11 2 5.6 6 16.5
66—70 31 3 9.5 4 12.9 7 22.5
71—75 45 4 9.0 3 6.7 7 15.5
>75 36 2 5.5 8* 22.2 10 27.8
* p < 0.05 versus mid-term death in patients <75 years of age.balloon pump, two worsening of a shoulder arthrosis, and one
deterioration of multiple sclerosis.
From a socio-economic point of view, most patients lived
at home without any assistance (89.4%) or with (6.4%) help of
relatives, while a small minority had to be placed in nursing
homes (3%) or remained hospitalized (1.2%).
3.5. Pain and discomfort
The burden of ICU treatment could no longer be
accurately quantified 1 year after discharge but important
pieces of information could still be collected: Despite an
apparently liberal use of opioids and sedatives, one patient
(0.6%) still reminded of severe pain and 33 others (19.8%) of
discomfort due to: permanent noise and illumination
(n = 17), recurrent nightmares for months (n = 12), panic
(n = 2), conflict with the nursing staff (n = 1), and amnesiaFig. 1. Distribution of K scores in 165 one-year survivors.(n = 1). Indeed, after such a long period of time, 85% of these
discomforts were rated minor by the patients. Accordingly,
81.4% of survivors stated that they would accept redo surgery
if necessary, 10.9% would hesitate, and only 7.7% would
definitely refuse.4. Discussion
Reliable prognostic information and the patient percep-
tion of his situation have been found the most important
factors for physicians facing life-support decisions for
critically ill patients [11]. Our study has documented the
absence of reliable predictive factors of ominous survival or
functional outcomes in cardiac surgical patients requiring5
days of ICU treatment.
There is no consensus on the definition of prolonged ICU
treatment. The following issues have guided our choice of 5
days: (A) The analysis of end-of-life practices in 31,417Table 7
Influence of various life-supporting procedures on late functional outcome
measured by the K score 1 year after discharge
Procedure K score 30—80
(with vs without)
p *
Ventilation 5 days 12/39 versus 34/126 ns
Dialysis 3/14 versus 43/151 ns
IABP 5/24 versus 41/141 ns
Reoperation 7/24 versus 39/141 ns
CPR 6/28 versus 40/137 ns
Defibrillation 3/20 versus 43/145 ns
IABP: intra aortic balloon pump; CPR: cardiopulmonary resuscitation.
* = x2-test.
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median ICU stay of 4 days and a median delay of 2.8 days until
the first treatment limitation was decided. (B) It has been
established that the worst ICU patients tend to die within 5
days [13]. (C) ICU mortality remains elevated for several
weeks: the SUPPORTstudy [11] found a median number of 14
ICU days before death among surgical patients. (D) All cardiac
patients still under ICU treatment at the fifth postoperative
day have at least one severe organ system failure [18]; at this
time the risk of poor outcome depends much more on the
evolution of this organ failure than on preprocedural patient
risk factors [19]. (E) Decisions of treatment withdrawal need
to be founded and limited to patients with no chance of
decent recovery; several days of full treatment allow
accurate estimation of the patient’s overall prognosis and
response to treatment; moreover, full treatment for several
days helps convincing the patient’s surrogates that money
saving is not the actual reason for treatment withdrawal.
On the other hand, two recent studies [20,21] have
concluded that outcome predictions based on organ dysfunc-
tion scores are not reliable during the first 14 days following
cardiac surgery. Unfortunately, this delay makes decisions of
treatment limitation much too late to substantially reduce
the amount of unnecessary patient suffering and waste of
medical resources.
Survival in this cohort of cardiac surgical patients
requiring prolonged ICU treatment is higher than those
predicted by nonspecific preoperative risk assessment
systems; likewise, it compares favorably with the outcome
of general ICU patients. These differences can be ascribed to
the fact that cardiac surgical patients initially present with a
correctible organ failure. The rather favorable mid-term
outcomes and the high proportion of patients able to resume
independent life (89%) demonstrate that prolonged ICU
treatment does neither provoke an accumulation of mid-
termmedical disasters nor induces tremendous hidden socio-
economical costs.
QOL is increasingly regarded as central to the definition of
success [18,22], or even as the most important outcome of
cardiac surgery [23]. Crude survival is considered a poor
marker of treatment efficiency for two reasons: First, low
mortality rates are linked with limited statistical power and,
thus, not qualified for outcome-directed quality assessment
studies [24]; second, patients with the worst preoperative
condition are those who benefit more from the operation [2].
Unfortunately, however, QOL is an observer-dependent
concept and the scores currently used to assess QOL scarcely
take into account the patients opinion; moreover, it has been
suggested that physicians tend to be too pessimistic
regarding prognoses and to provide more extensive treat-
ments than they would choose for themselves [11]. However,
there are no indications from this study that prolonged ICU
treatment produced major sufferings in a large number of
patients, nor that survival was achieved at the expense of the
patient’s quality of life [19].
Unrelieved pain and discomfort are still known problems
of ICUmanagement: The SUPPORTstudy [11] found moderate
to severe pain occurring at least half of the time in 12—32% of
critically ill patients; self-assessment in real time by 100
cancer patients from various medical ICUs revealed pain and
discomfort in nearly 75% of cases [25]. The low rate ofcomplaints from our patients is mostly attributable to recall
bias and minimization by patients interviewed for the first
time 1 year after treatment. Nonetheless, these recalls still
indicate that pain and discomfort have beenmanaged but not
eliminated; accordingly, further improvement in commu-
nication, patient comfort, as well as in analgesic and sedative
therapies, are still needed. Finally, the emergence of noise
and permanent lightening as the main source of discomfort
underscores the absolute necessity to minimize these
factors, especially at nighttime.
Resource consumption is another important issue of ICU
treatment analysis. It has been reported that 13.3% patient
days — and 16.7% of total ICU expenditure — are invested in
non-survivors [14]. These figures do not apply for cardiac
surgical patients: we found that treatment cessation at the
fifth ICU day in all patients who ultimately died in the hospital
would have reduced by 1.85% the ICU occupation time by
cardiac surgery patients. A similar analysis by Holmes et al.
[19] found comparable overall potential savings in ICU bed-
days.5. Limitations of the study
(1) Our main purpose was to identify possible predictors of
poor outcome in operated cardiac patients requiring
prolonged ICU treatment. Therefore, this study was not
designed to allow refined comparisons between the pre-
and the postoperative functional condition of cardiac
surgical patients.(2) The K score was chosen because it focuses on functional
disability. More sophisticated QOL scoring systems
measuring items such as emotional burden, poor social
integration, family disturbances, or decreased sexual
performances were considered not pertinent for treat-
ment withdrawal decisions.(3) A medium-sized single-center study allows avoiding bias
induced by inhomogeneous concepts of treatment. It
might be argued that a wide multicentric study could
identify additional markers of poor outcome. However,
systems needing a huge number of observations to reach
significance may retain some prognostic value for
cohorts, but they certainly do not fit for individual
treatment withdrawal decisions. Moreover, it can be
calculated that a sample size of over 32,500 patients
would be necessary to evidence a relationship between
risk factors occurring in around 3% of CPB patients — such
as gastrointestinal complications or severe hematologi-
cal disease — and a twofold increase in global mortality
or disability rate. And, it must be considered that at
present time patients who are at increased risk of
bleeding are mostly operated off pump.6. Conclusions
Accurate early predictors of poor vital and functional
outcomes are still lacking for cardiac surgery patients
requiring prolonged and complex ICU management. Acute
neurological damage is the sole factor increasing the risk of
long-term disability. In the initial phase of ICU treatment,
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several days of full ICU treatment should be allowed before
treatment limitation is decided.
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